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Abstract OBJECTIVE: The purpose of this research was to assess the dynamics of autonomic 
nervous system(ANS) and hemodynamic activity changes during uncomplicated 
pregnancy.
METHODS: We enrolled 36 pregnant women (mean age 29±4.8years) and a control 
group of 10 non-pregnant women (mean age 25.9±0.88years). The examination 
was performed in the 1st, 2nd, and 3rd trimester. Continuous registration of BP, 
ECG, and cardioimpedance was performed with Task Force Monitor 3040i. ANS 
activity was measured using the following parameters: HRV, BPV, BRS at rest, and 
in response to autonomic tests.
RESULTS: Compared to the 1st trimester, an increase in HR (73 vs. 92 bpm; 
p<0.001) and mean BP (80 vs. 85 mmHg, p<0.01) was observed in the 3rd trimester. 
In the 1st trimester, the BRS of pregnant women was insignificantly higher than in 
the controls (24.8 vs. 22.3 ms/mmHg); subsequently, it decreased significantly, to 
13.4 ms/mmHg in the 3rd trimester (p=0.0004). An increase in nLF (39.57±13.75 
vs. 58.73±15.55; p=0.001) and LF/HF ratio (1.03±0.76 vs. 1.85±0.8; p<0.00002) was 
revealed in HRV analysis conducted in the 3rd trimester, as compared to the 1st tri-
mester, along with a decrease in nHF (60.43±13.71 vs. 41.26±15.55; p<0.001). An 
increase in LF/HF-sBPV (1.05±0.48 vs. 1.58±0.44; p=0.01) was recorded in BPV 
analysis at rest in the 3rd trimester as compared to the respective 1st trimester value.
CONCLUSION: Our findings suggest that pregnancy is associated with dynamic 
changes in autonomic balance, namely doubled dominance of the sympathetic 
component. Hypervolemia seems the major factor responsible for autonomic and 
hemodynamic changes observed during pregnancy, as it causes an increase in BP 
and simultaneous decrease in BRS.
Abbreviations
BRS  - baroreceptors activity 
BP  - blood pressure 
BPV  - blood pressure variability 
ECG  - electrocardiography
HF  - high frequency
HR  - heart rate
HRV  - heart rate variability 
LF  - low frequency 
TFC  - total fluid content 
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INTRODUCTION
The autonomic nervous system (ANS) is responsible 
for cardiovascular, gastrointestinal, and urinary system 
control. Pregnancy is associated with adaptive changes 
in the functioning of those systems, in particular in 
maternal hemodynamics, which is accompanied by 
changing levels of various vasoactive hormones and 
metabolites. These changes are detectable very early, 
even at 4th week of gestation, and are nearly completed 
in the first half of pregnancy.
The results of previous studies suggest that maternal 
hemodynamic adaptation to pregnancy is most likely 
triggered by a primary fall in systemic vascular tone. 
According to the published data, cardiac output raises 
during pregnancy as the result of the fall in systemic 
vascular resistance and an expansion of blood volume 
that lead to a decreased afterload and an increased pre-
load, respectively. It has been proposed that hemody-
namic changes taking place during pregnancy occur 
through autonomic control mechanisms, but the exact 
role of the autonomic nervous system in those adapta-
tion processes is poorly understood (Fu & Levine 2009; 
Ekholm et al. 1997; Szymanska et al. 2008). Vascular 
tone is to a large extent modulated by the activity of the 
sympathetic nervous system interrelated to the release 
of placental hormones (Heiskanen et al. 2008; Rang et 
al. 2002; Lucini et al. 1999).
In contrast to the sympathetic activation, periph-
eral vascular resistance was found to be even lower in 
normal healthy pregnant women, during their late preg-
nancies. This finding suggests that the transduction of 
sympathetic impulse into vascular resistance is blunted 
during pregnancy. The mechanisms responsible for the 
blunted vascular transduction during pregnancy are 
unknown. The results of previous studies suggest that 
estrogens may decrease the transduction of sympathetic 
traffic into vascular resistance through local mecha-
nisms (Metsaars et al. 2006).
The results of previous studies of cardiac autonomic 
function in human pregnancy are inconclusive and sup-
plied fractional results by investigating the autonomic 
system in different gestational stages. The autonomic 
nerves, as well as end-organ responsiveness and circu-
latory hemodynamics are involved, and only indirect 
information about the complex cardiovascular reflex 
arc can be assessed by analyzing the heart rate and 
blood pressure responses (Moertl et al. 2009; Faber et al. 
2004). The purpose of this study was the evaluation of 
the sequential and dynamic changes of autonomic ner-
vous system activity, based on analysis of heart rate and 
blood pressure variability and autonomic tests (the Val-
salva maneuver, the cold pressor and the deep breathing 
tests, i.e. cardiovascular reflex tests) and hemodynamics 
throughout the entire pregnancy.
MATERIALS & METHODS
The study included 36 pregnant women (mean 
age 29±4.8 yrs) and 10 age- and gender-matched 
healthy volunteers (non-pregnant women; mean age 
29.5±5.2 yrs). All the measurements were taken three 
times: in the 1st (6–12 week), 2nd (18–24 week), and 
3rd trimester (30–35 week). The characteristics of the 
investigated group are presented in Table 1.
The exclusion criteria from the study were: diabetes 
mellitus, obesity, cardiovascular diseases (hyperten-
sion, coronary artery disease, valvular heart disease), 
gastrointestinal pathologies (e.g. inflammatory bowel 
disease), and renal or gynecological pathologies. More-
over, the patients were excluded if they had any known 
cardiac arrhythmias or have been taking medications 
that could interfere with the HRV measurement, such 
as calcium-channel blockers, beta-blockers, and tricy-
clic antidepressants.
Study protocol
HRV, BPV, BRS. The autonomic activity was assessed 
based on the heart rate variability (HRV), blood pres-
sure variability (BPV), and baroreflex sensitivity (BRS). 
After an overnight fast, continuous measurements of the 
ECG signal, beat-to-beat blood pressure, and cardio-
impedance signal were taken with Task Force Monitor 
3040i (CNSystem, Austria). Subsequently, the recorded 
ECG signal was subjected to frequency analysis (based 
on fast Fourier transformations). The following param-
eters were considered: TP – total power, i.e. the variance 
of RR intervals over the selected time interval, VLF 
– power of very low frequency component (0.0033–
0.04 Hz), LF power – power of the low frequency 
component (0.04–0.15 Hz), HF power – power of high 
frequency component (0.15–0.4 Hz), LF/HF ratio – 
ratio of LF power to HF power, and normalized units: 
nLF and nHF (Pinna et al. 2007; Maestri et al. 2007).
Tab. 1. Clinical characteristic of the investigated women.
Trimester
1st 
(n=35)
2nd 
(n=32)
3rd 
(n=22)
Non-pregnant
(n=10)
p-value
Age 29±4.08 29±4.08 29±4.08 25.9±0.876 0.02
Height [m] 1.68±0.07 1.67±0.07 1.68±0.07 1.664±0.6 NS
Weight[kg] 63.8±9.95 68.2±10 75±11.3 56.9±5.259 0.03
BMI [kg/m2] 22.6±2.82 24.3±3.04 26.4±3.24 20.52±1.2 0.00002
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Autonomic tests. All tests were performed in the 
morning under standard conditions, in a quiet and 
relaxing environment, after 12 hours of overnight fast 
(Jaradeh & Prieto 2003).
Deep breathing test (DB)
The DB test was chosen as a method of estimating 
parasympathetic activity (Zygmunt & Stanczyk 2010). 
Regular deep breathing at the rate of 6 breaths per 
minute (5 seconds inspiration and 5 seconds expira-
tion) was performed to estimate: ΔI–E – the difference 
between maximal heart rate during inspiration and the 
minimal heart rate during expiration, E/I ratio – mean 
ratio of the longest RR interval during expiration to the 
shortest RR interval during inspiration, counted from 6 
consecutive cycles, DBD – the deep breath difference, 
RSA – respiratory arrhythmia index, and parameters of 
HRV analysis.
Valsalva maneuver
This maneuver provides an excellent test of the integ-
rity of both arterial and cardiopulmonary baroreflex 
arc (Ekholm et al. 1996; Zygmunt & Stanczyk 2010; 
Schönauer et al. 2008). The Valsalva test comprises an 
abrupt transient voluntary elevation of intra-thoracic 
and intra-abdominal pressure provoked by straining. 
The investigated subject blows into a mouth-piece of 
the manometer to 40 mmHg for 15 s, with continuous 
ECG and BP monitoring before, during and after the 
procedure. For evaluating the Valsalva test, the Val-
salva ratio (VR), which is the index of cardiac para-
sympathetic efferent activity, is used. Arterial pressure 
elevations after the release of Valsalva straining provide 
acceptable estimates of preceding sympathetic nerve 
responses and control mechanisms (Ekholm & Erkkola 
1997; Rang et al. 2002).
Cold Pressor Test
The Cold Pressor Test was performed by placing the 
subject’s hand, up to the wrist, in ice water (0–4 °C) for 
120 s. This elicits an instantaneous local and generalized 
vasoconstriction in the skin and the skeletal muscles, 
which is not only a direct effect of cold on the local skin 
vessels, but also a result of pain-activating spinal cord 
and hypothalamic reflexes. The heart rate increases to 
a peak value within the first 30 s and returns to base-
line level up to one minute. Due to an increase in total 
peripheral resistance, arterial pressure increases, with 
maximum in the second minute of the test. The pres-
sor response is strongly correlated with the increase 
of muscle sympathetic neural activity, as measured by 
direct recordings of the latter (Mourot et al. 2009).
The study conformed to ethical guidelines outlined 
in the Declaration of Helsinki and was approved by the 
Jagiellonian University Bioethical Committee (decision 
no. KBET/151/B/2011). All subjects included in the 
study were instructed about its purpose and gave their 
written informed consent to participate in the project.
Statistics
Database management and statistical analyses were 
performed using the Statistica for Windows, version 
7.0 PL (StatSoft the Inc., Tulsa OK, USA). All values 
are expressed as percentages or means ± SDs. Normal 
distribution of the analyzed variables was verified with 
Shapiro-Wilk test. In the case non-normally-distributed 
variables, they were subjected to a logarithmic transfor-
mation prior to further analysis. Depending on a distri-
bution, either the paired Student’s t-test or Wilcoxon’s 
signed rank test were used for intergroup comparisons 
of quantitative variables. Associations between HRV, 
BPV and hemodynamics parameters were studied with 
the Spearman’s correlation coefficients. Statistical sig-
nificance of all the tests was set at p<0.05.
RESULTS
Hemodynamic changes:
Compared to the 1st trimester, a significant increase 
in maternal heart rate HR was documented in the 3rd 
trimester (73 vs. 92 bpm; p<0.001). Although mean 
blood pressure remained generally stable, a significant 
increase in mBP (80 vs. 85 mmHg, p=0.002), and a 
significant decrease in diastolic blood pressure (70 vs. 
67.5 mmHg; p=0.02) were observed in the 3rd and 2nd 
trimester, respectively. In contrast, systolic blood pres-
Tab. 2. Hemodynamic measurements taken at rest in pregnant and non-pregnant women. 
Trimester 1st 2nd 3rd Non-pregnant p-value
HR [bpm] 73±6.9 80.8±9.08 92±14* 75±10& 0.000001&*
dBP [mm Hg] 70±8.2 67.5±7.97 73±8.1 75±7.8 0.0207
sBP[mm Hg] 108±12 106±10.4 113±10 112±6.1 0.0994
mBP [mm Hg] 80±9.3 78.4±8.72 85±8.3* 89±8.4 0.0025*
BRS [ms/mmHg] 24.8±12.1 15.6±7.7* 13.4±7.0* 22.3±11.2& 0.0004*&
TFC [1/kOhm] 28.0±5.9 32.9±10* 28.8±6.5 27.1±10.4# 0.02*#
* – significant differences between the 1st and 2nd or 3rd trimester; # – significant differences between the controls and pregnant women in 
the 1st trimester; & – significant differences between the controls and pregnant women in the 3rd trimester. HR – heart rate; dBP – diastolic 
blood pressure; sBP – systolic blood pressure; mBP – mean blood pressure; BRS – baroreflex sensitivity, TFC – Total fluid content.
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sure remained unchanged throughout the entire preg-
nancy (Table 2).
Whereas BRS of pregnant women did not differ 
significantly from that of the controls (24.8 vs. 
22.3 ms/mmHg) in the 1st trimester, it decreased sig-
nificantly, to 13.4 ms/mmHg, in the 3rd trimester 
(p=0.0004). Similar changes of BRS were noted in 
during DB and CPT (Table 3). In the 2nd trimester, 
the total fluid content (TFC) of pregnant women was 
higher than in the controls; a gradual increase in this 
parameter was observed between the 1st and 2nd tri-
mester (Table 2).
HRV
Compared to the 1st trimester, an increase in nLF 
(39.57±13.71 vs. 58.73±15.55; p<0.001) and LF/HF ratio 
(1.03±0.76 vs. 1.85±0.96; p<0.002) was documented in 
HRV analysis in the 3rd trimester, along with a decrease 
in nHF (60.43±13.71 vs. 41.28±15.55; p<0.001).
No significant differences in the HRV response to 
DB were observed in pregnant women, either com-
pared to the controls or on trimester-to-trimester com-
parisons. The only exception pertained to HF in the 3rd 
trimester which was significantly lower than in the 1st 
trimester (Table 4).
A significant decrease in HF and LF values was 
observed in response to CPT in the 3rd trimester 
(Figure 1). The CPT-provoked decrease turned out to be 
most pronounced in the case of HF. The changes of HRV 
indices pointed to a gradual increase of sympathetic 
activity and the blunted parasympathetic component.
BPV
Compared to the 1st trimester, an increase in diastolic 
LF/HF-dBPV (1.81±0.81 vs. 1.15±0.42; p=0.02) and 
systolic LF/HF-sBPV (1.12±0.42 vs. 1.81±0.92 p=0.01) 
was observed in the 3rd trimester in BPV analysis con-
ducted at rest (Figure 2).
Tab. 3. Changes in baroreceptor activity (BRS) documented at rest and following DB and CPT in pregnant and non-pregnant women. 
Trimester 1st 2nd 3rd Non-pregnant p-value
At rest
BRS [ms/mmHg] 24.8±12.1 15.6±7.7* 13.4±7.0* 22.3±11.2& 0.0004*&
During DB
BRS [ms/mmHg] 21.9±7 18.3±7.3 16.37±17.7* 19.58±8.36 0.01*
During CPT
BRS [ms/mmHg] 18.76±8.2 16.8±7.3 13.2±9.5* 16.5±9.36 0.01*
* – significant differences between the 1st and 2nd or 3rd trimester; & – significant differences between the controls and pregnant women in 
the 3rd trimester. BRS – baroreflex sensitivity.
Tab. 4. Changes in HRV parameters changes observed at rest and during DB test in pregnant and non-pregnant women. 
Trimester 1st 2nd 3rd Non-pregnant p-value
Rest TP [ms2] 6.81±0.84 6.53±1.25 6.93±2.05 7.02±0.78 NS
LF [ms2] 5.58±0.85 5.36±1.07 5.13±1.83 6.28±0.77 0.02&
HF [ms2] 6.04±1.09 5.20±1.30 4.6±2.43 5.8±1.02 0.003*
nLF 39.57±13.71 52.71±14.23 58.73±15.55 58.69±15.43 0.0002*
nHF 60.43±13.71 47.28±14.23 41.26±15.55 41.31±15.43 0.00002*/0.0007#
LF/HF 1.03±0.76 1.38±0.84 1.85±0.96 1.42±0.68 0.04&/0.00002*
DB test TP [ms2] 8.67±1.07 8.12±1.14 7.5±1.65 8.53±0.7 0.003*
LF [ms2] 8.55±1.11 7.93±1.34 6.44±1.47 8.38±0.81 0.0001&/0.0007*
HF [ms2] 5.72±1.02 5.36±1.01 4.31±1.71 5.61±0.98 0.0004*/0.02&
nLF 86.38±5.37 84.16±8.71 83.86±8.39 86.77±7.53 NS
nHF 13.61±5.37 15.83±8.71 16.13±8.39 13.22±7.53 NS
LF/HF 15.14±13.31 13.88±14.01 8.67±8.44 18.45±21.92 NS
* – significant differences between the 1st and 2nd or 3rd trimester; # – significant differences between the controls and pregnant women in 
the 1st trimester; & – significant differences between the controls and pregnant women in the 3rd trimester. TP – total power – the variance 
of RR intervals over the selected time interval, LF – power of the low frequency component (0.04–0.15 Hz), HF – power of high frequency 
component (0.15–0.4 Hz), LF/HF ratio – ratio of LF to HF power; nLF and nHF – normalized units of LF and HF.
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A decrease in post-DB test values of normalized dia-
stolic LFnu-dBPV (63.22±11.74 vs. 54.82±9.31 p=0.01) 
and systolic LFnu-sBPV (57.21±11.78 vs. 49.53±7.78 
p=0.016) was documented between the 1st and 3rd tri-
mester of pregnancy.
Furthermore, a gradual decrease in post-CPT dia-
stolic LF-dBPV and HF-dBPV, and systolic LF-sBPV 
and HF-sBPV was observed between the 1st and 3rd
trimester, along with significant increase in LF/HF-
dBPV and LF/HF-dBPV ratios (Table 5). The changes 
documented in BPV analysis corresponded to a gradual 
increase in sympathetic activity and weaker response to 
additional sympathetic stimulation.
Autonomic tests
The indices of DB test, E/I ratio, ΔI–E, DBD, and RSA, 
were normal; however, a significant decrease in their 
values was documented in the 3rd trimester. Similar 
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Fig. 1. Changes in heart rate variability (HRV) parameters, LF and 
HF, documented before, during and after CPT at various stages 
of pregnancy and among non-pregnant women. CPT – cold 
pressor test.
Fig. 2. Changes in blood pressure variability (BPV) parameter LF/HF 
ratio at rest documented at various stages of pregnancy and 
among non-pregnant women. LF/HF-dBPV-ratio in diastolic BPV 
LF/HF-sBPV-ratio in systolic BPV.
Tab. 5. Changes in BPV parameters documented before, during and after CPT in pregnant and non-pregnant women. 
Trimester 1st 2nd 3rd Non-pregnant p-value
Before 
CPT
LF–dBPV 2.52±0.78 2.50±1.12 1.77±0.54 3.11±2.35 0.0005*/0.04&
HF–dBPV 0.73±0.29 0.76±0.42 0.45±0.14 0.82±0.58 0.001*/0.016&
LF–sBPV 2.94±0.89 2.88±1.78 2.36±0.96 3.70±2.15 NS
HF–sBPV 0.93±0.49 0.92±0.72 0.58±0.17 1.25±1.55 0.001*
LF/HF–dBPV 1.15±0.42 1.21±0.59 1.81±0.81 1.49±0.44 0.02*
LF/HF–sBPV 1.12±0.42 1.22±0.54 1.81±0.92 1.51±0.46 0.01*
CPT LF–dBPV 2.38±0.69 2.45±1.14 1.72±0.57 2.37±1.04 0.001*/0.006&
HF–dBPV 0.71±0.27 0.73±0.43 0.44±0.13 0.86±0.64 0.00005*/0.002&
LF–sBPV 2.76±0.91 2.74±1.85 2.22±0.85 3.25±1.65 0.04*
HF–sBPV 0.93±0.63 0.93±0.81 0.59±0.17 1.13±0.94 0.01*/0.04&
LF/HF–dBPV 1.19±0.51 1.47±0.72 2.43±1.78 1.58±0.51 0.01*/0.047&
LF/HF–sBPV 1.16±0.48 1.43±0.67 2.28±1.58 1.57±0.44 0.01*/0.047&
After 
CPT
LF–dBPV 2.25±0.66 2.31±1.65 1.69±0.54 2.46±1.03 0.001*/0.03&
HF–dBPV 0.71±0.26 0.72±0.50 0.44±0.13 0.79±0.62 0.004*/0.038&
LF–sBPV 2.61±0.85 2.56±1.95 2.18±0.89 3.27±1.93 0.04&
HF–sBPV 0.94±0.57 0.91±0.83 0.59±0.17 1.33±1.66 0.004*/0.005&
LF/HF–dBPV 1.02±0.39 2.31±5.7 2.36±1.66 1.81±1.37 0.007*/0.028&
LF/HF–sBPV 0.98±0.36 1.28±0.58 2.25±1.52 1.71±1.18 0.005*/0.02&
* – significant differences between the 1st and 2nd or 3rd trimester ; # – significant differences between the controls and pregnant women 
in the 1st trimester; & – significant differences between the controls and pregnant women in the 3rd trimester. LF–BPV – systolic or diastolic 
power of the low frequency component (0.04–0.15 Hz), HF–BPV – systolic or diastolic power of high frequency component (0.15–0.4 Hz), 
LF/HF–BPV – systolic or diastolic ratio of LF to HF power.
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changes occurred in response to Valsalva maneuver 
(VM) in pregnant women. All these findings point to 
blunted parasympathetic activity.
A significant decrease in the indices of CPT, i.e. Δ 
sBP, Δ dBP, and Δ HR, was observed in the 3rd trimester 
as compared to the respective values determined in the 
1st trimester and among the controls (Table 6). These 
changes corresponded to a gradual decrease in sympa-
thetic response to sympathetic stimulation.
Correlation
In the 2nd trimester, TFC correlated positively with sys-
tolic and diastolic blood pressure variability parameters: 
LF/HF-sBPV (r=0.39; p=0.02), LFnu-dBPV (r=0.34; 
p=0.03), and LF/HF-dBPV (r=0.4; p=0.01). 
DISCUSSION
The aim of this study was to evaluate the pathophysi-
ological importance of the dynamics of autonomic ner-
vous system activity and hemodynamic activity among 
pregnant women. Consistently with our hypotheses, we 
observed that: 
In the 2nd trimester, the total fluid content (TFC) of 
pregnant women was higher than in the controls, and 
gradually increased between the 1st and 2nd trimester.
The values of sympathetic activity indices, LF, 
nLF, and LF/HF, were higher in the 3rd than in the 1st 
trimester.
The changes in BPV indices occurring between the 
1st and 3rd trimester, namely an increase in diastolic and 
systolic LF/HF, corresponded to a gradual increase in 
sympathetic activity.
A gradual decrease in sympathetic activity and 
blunted response to parasympathetic activation are 
observed between the 1st and 3rd trimester as a result of 
the autonomic response tests (DB, VM).
Blunted response to sympathetic activation during 
CPT was documented in the 3rd trimester of pregnancy.
The most prominent cardiovascular changes 
take place in early pregnancy. Potential mechanisms 
responsible for the decrease in systemic vascular resis-
tance observed during pregnancy in humans include 
the development of a new uteroplacental vascular 
circuit, the retention of fluids leading to expansion of 
blood volume, and primary systemic/venous vasodila-
tion. However, these mechanisms are not sufficient to 
explain the systemic decrease in vascular resistance, 
since most of the changes occur outside the uteropla-
cental circulation. Vascular tone is to a large extent 
modulated by the activity of the sympathetic ner-
vous system. However, increased activity of the latter 
in advanced pregnancy is reflected by a decrease in 
peripheral resistance (Heiskanen et al. 2008; Rang et 
al. 2002; Lucini et al. 1999). The mechanism underly-
ing the primary reduction in peripheral vascular resis-
tance in early pregnancy is unclear, but the endothelial 
release of nitric oxide has been proposed as a major 
determinant of this phenomenon. In addition, cardiac 
output increases very early in the pregnancy as a result 
of increased heart rate and stroke volume. Increased 
shear stress, resulting from augmented flow in both 
systemic and resistance arteries, may be reflected by 
enhanced release of nitric oxide (Fu & Levine 2009; 
Swiatek & Chazan 1999; Ekholm et al. 1997). Stepwise 
expansion of blood volume is postulated a significant 
determinant of these changes; it is observed as early 
as in the 4th week of gestation, causes an increase in 
preload, and precedes the activation of the RAS system 
and elevation of the progesterone level (Metsaars et al. 
2006). We observed an increase in total fluid contents 
(TFC) in the 2nd trimester, with a return to the baseline 
level in the 3rd trimester. These findings are partially 
consistent with the results published by Lukaski et al. 
Tab. 6. Parameters of autonomic system tests documented in pregnant and non-pregnant women. 
Trimester 1st 2nd 3rd Non-pregnant p-value
DB test E/I 1.39±0.16 1.32±0.13 1.12±0.43 1.40±0.16 0.002*/0.01&
ΔI – E 19.7±2.4 13.213.2 10.213.2 22.3±2.8 0.002*&
DBD 221±79 18484 15494 232±69 0.002*&
RSA 0.24±0.08 0.200.06 0.190.06 0.28±0.08 0.002*&
Valsalva test VR ratio 2.12±0.53 1.95±0.71 1.31±0.21 1.33±0.17 0.000004*#
Cold pressor 
test
Δ sBP 11.25±7.66 11.71±15.08 8.86±5.4& 13.2±8.36 0.01&
Δ dBP 7.11±5.04 8.27±10.2 6.60±8.9 8.22±5.66 NS
Δ HR 20.8±8.4 18.6±8.4 17.32±6.3 19.58±8.36 NS
* – significant differences between the 1st and 2nd or 3rd trimester; # – significant differences between the controls and pregnant women 
in the 1st trimester; & – significant differences between the controls and pregnant women in the 3rd trimester. E/I ratio – mean ratio of the 
longest RR interval during expiration to the shortest RR interval during inspiration counted from 6 consecutive cycles. ΔI–E – the difference 
between maximal heart rate during inspiration and minimal during expiration, DBD – the deep breath difference, RSA – respiratory 
arrhythmia index, HR – heart rate, BPs – systolic blood pressure, BPd – diastolic blood pressure, VR – Valsalva ratio – the ratio of the R-R 
interval between the longest R-R interval during the test and the shortest R-R interval after the test, p – level of statistical significance. Data 
are presented as mean arithmetical values ± SD.
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(1994); however, these authors did not analyze the 
changes of TFC in other trimesters.
Circulatory baroreflexes constitute important mech-
anism involved in the maintenance of the blood pres-
sure and flow. However, the results of previous studies 
of baroreflex function in pregnant woman are incon-
clusive, as all increased, unchanged, or decreased car-
diovagal baroreflex sensitivity (BRS) has been reported 
(Rang et al. 2002; Faber et al. 2004; Voss et al. 2000). 
These discrepancies may result from methodologi-
cal differences between previous studies and/or dif-
ferences in analyzed stages of gestation. In contrast, 
the results of numerous studies regarding cardiovagal 
baroreflex dysfunction in gestational hypertension and 
preeclampsia are relatively consistent in documenting 
impaired baroreflex function. Our study of healthy 
women revealed a decrease in BRS in the 2nd and 3rd 
trimester. The marked sympathetic activation during 
the third trimester of gestation, documented in both 
our and previous studies, points to inhibitory restraint 
of central sympathetic outflow as one potential cause of 
BRS fall (Faber et al. 2004).
While cardiac vagal activity is decreased in normal 
pregnancy, the sympathetic activity is increased in late 
gestation. Therefore, autonomic nervous activity seems 
to be shifted towards a lower sympathetic and higher 
vagal modulation in the first trimester, and towards a 
higher sympathetic and lower vagal modulation later 
in the pregnancy (Ekholm & Erkkola 1996; Ekholm et 
al. 1997; Kuo et al. 2000; Voss et al. 2000). This is con-
sistent with our findings on autonomic response to 
stimuli, as HRV parameters documented in our study 
corresponded to a gradual decrease in response to both 
sympathetic and parasympathetic stimulation.
The respiratory fluctuations in the heart rate are 
likely to be primarily mediated by parasympathetic 
efferent pathways. Loss of the normal respiratory sinus 
arrhythmia is often the earliest sign of autonomic 
neuropathy in diabetes mellitus [20]. Inspiration and 
expiration at a constant rate accentuate the normal 
respiratory sinus arrhythmia observed in most individ-
uals (Ekholm & Erkkola 1996; Rang et al. 2002; Lahiri 
et al. 2008). Our study documented a decrease in E/I 
ratio, ΔI–E, DBD, and RSA in response to both DB test 
and Valsalva maneuver (VM) performed in the 3rd tri-
mester. These results are consistent with data reported 
by Souma et al. (1983), who demonstrated a downward 
trend in the Valsalva ratio of pregnant women up to 
the 32nd week of gestation. This suggests that blunted 
response to both stimuli may result from a progressive 
decrease in the vagal activity of pregnant women.
The pressor response is strongly correlated with an 
increase in muscle sympathetic neural activity, as shown 
by direct recording of the latter (Rang et al. 2002). Our 
findings are consistent with the results published by 
Greenwood and Avery (Greenwood et al. 1998; 2003; 
Avery & Wolfe 2001), who observed weaker response 
of pregnant women to sympathetic stimulation during 
orthostatic stress or exercise (Avery & Wolfe 2001). 
We showed a decrease in CPT-provoked diastolic LF-
dBPV and HF-dBPV, and systolic LF-sBPV and HF-
sBPV between the 1st and 3rd trimester, along with an 
increase in LF/HF-dBPV and LF/HF-BPV ratios. Also 
the indices of CPT, Δ sBP, Δ dBP, and Δ HR, decreased 
between the 1st and 3rd trimester. These changes sug-
gest a down regulation of adrenergic receptors resulting 
from prolonged sympathetic stimulation, thus explain-
ing the blunted transduction of sympathetic impulse 
into vascular resistance during pregnancy.
CONCLUSIONS
Maternal cardiovascular adaptation to pregnancy 
involves dramatic changes in the activity of ANS. Those 
changes follow characteristic pattern. An increase in 
HR and BP results from central sympathetic outflow 
with decreased baroreceptor inhibition. Our findings 
suggest that hypervolemia, which is caused by the cre-
ation of additional placental circulation and limited 
distribution of blood to several areas, and by the activa-
tion both sympathetic and RAS systems, constitutes the 
primary trigger of the autonomic and hemodynamic 
changes.
In conclusion, combined measurement and estima-
tion of cardiovascular and autonomic system activity 
parameters are vital for understanding the physiology 
and pathophysiology of cardiovascular adaptations 
in pregnant women, and for recognizing early patho-
physiologic changes that may disturb development of 
gestation.
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